Unum Therapeutics, Inc. (UMRX)


Stock Price Forecast

Oct. 5, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Unum Therapeutics, Inc. chart...

About the Company

Unum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient’s immune system to cure cancer. The firm’s technologies include Antibody-Coupled T-cell Receptor, which is a chimeric protein that binds to tumor targeting antibodies. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Cambridge, MA.

Sector

Health Technology

Industry

Biotechnology

Employees

72

CEO

Charles Wilson

Exchange

NASDAQ

Website

http://www.unumrx.com

$24M

Total Revenue

72

Employees

$73M

Market Capitalization

-3.13

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $UMRX News

Unum (UNM) Enhances Employee Well-Being With Unum Care Hub

4d ago, source: Nasdaq

Unum Group UNM recently announced the launch of Unum Care Hub to aid employers in taking proper care of their employees. Unum ...

Unum Care Hub will help employers provide support for top leave and disability drivers

5d ago, source:

Unum (NYSE: UNM), a leading provider of financial protection benefits in the U.S., is launching Unum Care Hub, a suite of ...

Appointments for SunLife and Unum

14d ago, source: covermagazine.co.uk

SunLife adds Victoria Heath as chief marketing officer and Unum welcomes Lio Lopez-Welsch as chief information and digital ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...